Forward-looking statements are subject to a number of risks and uncertainties, including but not limited to, risks and uncertainties associated with, among other things, the impact of economic, competitive, and other factors affecting our operations, markets, products, and performance. Expected, actual results, performance, or achievements could differ materially from those contemplated, expressed, or implied by the forward-looking statements contained herein. The words "anticipate," "believe," "estimate," "may," "intend," "expect," and similar expressions identify such forward-looking statements. products.įor more information about Can B Corp., please visit: įorward-looking statements and risks and uncertainties discussed in this release contain forward-looking statements. and our comprehensive line of high quality products, please visit: and follow Can B Corp on Instagram and Facebook, or visit one of the 1,000+ retail outlets that carry Can B Corp. operates R&D and production facilities in Lacey, WA, and Florida. Can B utilizes multi-channel distribution to reach consumers, including medical facilities, doctor offices, retailers, online and direct. (OTCQB: CANB) is a health & wellness company providing the highest quality hemp derived cannabinoid products, including under its own brands of Canbiola, Seven Chakras, NuWellness, Pure Leaf Oil and Duramed. Investors Hangout is a proud sponsor of "Stock Day," and Stock Day Media encourages listeners to visit the company's message board at. To hear Marco Alfonsi's entire interview, follow the link to the podcast here. To close the interview, Alfonsi elaborated on the Company's significant growth, and encouraged listeners and shareholders to keep up-to-date on their current plans and projects. "We've been able to increase our revenues and margins for the simple reason that we are able to create these isomers." "CBD is still a very low price, but once you convert that isolate into an isomer the price jumps," he explained, before elaborating on the different isomers. "Right now we are able to do Delta-8," explained Alfonsi. "What kind of new isomers are scheduled to be released within the next few months?" asked Jolly. "We were able to secure the American Development Partners to create and raise up to $200 million to build as many as 50 consumption lounges that are available to be assigned to our labs." "With American Development Partners, it is a new concept for us," continued Alfonsi. "We have final products that are ready to be shipped to Brazil, and hopefully local physicians will be writing scripts on behalf of our products for their patients." "In March, we signed the Brazilian Joint Venture with PrimeX," said Alfonsi, adding that CBD was not legal in Brazil until recently. Jolly then commented on the Company's recently announced partnerships with PrimeX and American Development Partners. "We are now in Michigan, where we have doubled our business," he shared, adding that the Company is also doing business in New York. "Our third operating division is Duramed, which is our medical device company," said Alfonsi, before elaborating on the Company's wearable technology. "Once opened in locations where State and Federal laws allow, you'll be able to purchase CBD, Delta-8, or Delta-10 products, and still have the ability to enjoy them in a lounge, which in the evening will turn into a nightclub with live entertainment," he shared, adding that "the lounge will also serve infused beverages and have that CBD Experience being located adjacent to an actual production lab".
"With our Miami operation, we have modeled a consumption lounge adjacent to our lab production operations and hope to open similar operations in select cities ove the next several months.
#Best micro cap stocks 2013 full
"We're able to be vertically integrated from biomass and hemp crude thru to isolate, and a full line of retain CBD products and various isomers." "We increased our balance sheet assets to over $16 million as of 12-31-2021," said Alfonsi. "For Q3 we made some major acquisitions," he shared. "Our second operating division is the hemp division," continued Alfonsi.
"We are now NSF approved which allows us the ability to bid for major drug and grocery chain store business for the first time." "Our first division is Pure Health Products," he explained.
is a health and wellness company, and we have five operating divisions," shared Alfonsi, adding that the majority of revenues are currently being generated through three of these divisions. Jolly began the interview by asking about the Company's background and current projects. CEO of the Company, Marco Alfonsi, joined Stock Day host Everett Jolly. (OTCQB: CANB) ("the Company"), a health & wellness company providing the highest quality hemp derived cannabinoid products, including under its own brands of Canbiola, Seven Chakras, NuWellness, Pure Leaf Oil and Duramed. April 20, 2022) - The Stock Day Podcast welcomed Can B Corp.
0 kommentar(er)
